• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Amneal Gets FDA Approval For Propofol Injectable Emulsion Single Dose Vials

    BUSINESSWIRE

    Propofol Europe Offers EU GMP Approved Anesthesia Drug Mfg

    PRESS RELEASE

    Aspiro`s Generic Propofol Receives Approval in US

    FDA

    Enforcement Report - Week of September 21, 2022

    FDA

    Hospira Issues A Voluntary Nationwide Recall For One Lot of Propofol Injectable

    FDA

    Genixus Introduces Propofol to be Delivered Within KinetiX RTA Syringe Platform

    PRNEWSWIRE

    Enforcement Report - Week of August 3, 2022

    FDA

    Hospira issues a recall for propofol due to visible particulate

    ENDPTS

    Hospira Issues a Voluntary Nationwide Recall for One Lot of Propofol Injectable Emulsion

    FDA

    Avet Pharma Announces Approval and Launch of Propofol Injectable Emulsion

    PRNEWSWIRE

    Emcure Pharms` Generic Propofol Receives Approval In US

    FDA

    Fine chemicals: Axyntis relocates the production of pharmaceutical active ingredients

    LESECHOS

    Dexmedetomidine Ties Propofol for Intubated Adults With Sepsis

    MEDPAGE

    Diprivan® (Propofol) Injectable Emulsion, USP First Product Available Fresenius

    BUSINESSWIRE

    Innopharma`s Generic Propofol Receives Approval In US

    FDA

    Sedative that Received FDA Emergency Use Authorization Now from Fresenius Kabi

    BUSINESSWIRE

    Bachem ensures global market supply of the API Propofol from Swiss production

    PRESS RELEASE

    Bachem injects a million to accelerate its production of propofol

    ZONEBOURSE

    Hikma responds to COVID-19 shortage with launch of Propofol Inj Emulsion, USP

    PR NEWSWIRE

    FDA Reports More Shortages of Drugs Used to Put COVID-19 Patients on Ventilators

    RAPS

    Coronavirus demand causes shortages of anesthetics, painkillers

    FIERCE PHARMA

    Propofol Injectable Emulsion -Drug shortage

    FDA

    Dr Reddy`s launches injection for anesthesia and sedation in US market

    BUSINESS STANDARD

    Dr Reddys Labs ` Generic Propofol Receives Approval in US

    FDA

    Anvisa Suspends 32 lots of Diprivan

    ANVISA

    Diprivan®(Propofol): Fresenius Kabi USA, LLC, v. BioQ Pharma Incorporated

    PATENT LITIGATION

    Diprivan® (Propofol) : Fresenius Kabi USA v. Bioq Pharma

    PATENT LITIGATION

    Gathering: Medicines Diprivan and Depakote

    FDA

    Pharmascience Inc. Recalls pms-PROPOFOL

    HEALTH CANADA

    Pharmascience Inc. Recalls Propofol Due To Contamination By Foreign Particles

    HEALTH CANADA

    Hospira Inc., Ongoing Class I recall of Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vials, packaged in 5 Units per carton, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30. because of Temperature Abuse: Products experienced uncontrolled temperature excursions during transit.

    FDA

    Hospira Inc., Ongoing Class II recall of Propofol Injectable Emulsion, 1%, 200 mg/20 mL, (10mg/mL), 20 mL, Single patient infusion vial, Contains Benzyl Alcohol, For I.V. Administration, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4699-30 because of Presence of Particulate Matter: The firm received a complaint of an embedded particulate in the neck of one vial composed primarily of iron.

    FDA

    Recall: PMS-Propofol

    HEALTHY CANADIANS

    Claris Confirms Patent Challenge for Generic Propofol in US

    THE ECONOMIC TIMES

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.